$INTT

InTest (INTT) Q2 2026 Earnings Call Transcript

InTest (INTT) reported Q2 2026 revenue of $35.3M, up 25.5% YoY, with semi orders $12.0M (+64% YoY) and backlog $45.4M (+19.8% YoY). Full-year guidance raised to $135M-$140M. Gross margin was 40.5% and adjusted EBITDA $2.2M. CFO cited a material weakness at Alfamation.

Original reporting
Published Aug 11, 2026, 3:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 4:08 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
InTest (INTT) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$INTTNeutralMed
01

Why it matters

Traders can reprice the stock on the combination of raised FY revenue guidance, Q3 revenue and gross margin guidance, and the risk overhang from a material weakness at the Alfamation division.

02

Market read

Guidance raises and backlog growth support a demand recovery narrative, while gross margin decline and internal-control remediation risk can cap the multiple.

03

What to watch

The Alfamation internal control material weakness and remediation timeline could create near-term operational friction, potentially affecting delivery schedules and customer acceptance testing.

Relevance 8/10Novelty 8/10Timing: pre-market today, following the Q2 2026 earnings call and guidance update

Background

InTest reported Q2 2026 results with a mix shift toward non-semi markets and discussed semiconductor back-end capacity dynamics.

Company-level read

Ticker impact

$INTTNeutralMedium confidence
Context

InTest raised full-year revenue guidance to $135 million to $140 million and guided Q3 revenue to $33 million to $35 million.

Expected impact

Likely positive bias on guidance, with volatility risk around internal-control remediation and mix-driven gross margin.

Evidence & confidence

The article discloses multiple fresh datapoints (raised FY guide, Q3 guide, backlog growth, and a newly cited material weakness) that can move expectations, but it is still an earnings-call transcript without explicit consensus comparisons.

Market effects

Signals potential recovery in semiconductor back-end testing demand while highlighting margin sensitivity to automotive project mix.

Defense/Aerospace orders growth points to continued U.S. DoD procurement tailwinds.

Limited direct global macro linkage; mostly company-specific demand and execution updates.

Counterpoint

The raised revenue outlook may be driven by timing and mix shifts (higher-contribution revenue pushed into Q3) rather than durable margin expansion, so upside could fade if gross margin fails to hold.

Key entities

  • InTest Corporation

    Reported Q2 2026 results, raised full-year revenue guidance, and disclosed a material weakness at the Alfamation division.

  • Rich Rogoff

    CEO who discussed semiconductor back-end cycle capacity and shipment timing.

  • Duncan Gilmour

    CFO who cited the Alfamation material weakness and provided guidance details.

Related articles

$INTTMed

INTEST CORP (INTT): Results of Operations and Financial Condition

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 intt-20260810xexx991.htm EX-99.1 Document Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Strong Second Quarter 2026 Revenue of $35.3 Million EPS of $0.04 and Adjusted EPS (Non-GAAP) of $0.09 • Second

$INTTMed

Why is inTest stock climbing today?

inTest Corp (INTT) shares rose 1.7% in pre-open trading after Northland upgraded the stock to “outperform” from “market perform” and set a $15.00 price target. Northland cited inTest’s preliminary Q2 2026 revenue estimate of about $35M and raised full-year 2026 revenue guidance to $135M-$140M, while noting a planned 220 bps gross margin reduction.

$INTTMed

INTEST CORP (INTT): Results of Operations and Financial Condition

INTEST CORP (INTT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 intt-20260731xpaexx991.htm EX-99.1 Document Exhibit 99.1 NEWS RELEASE 804 EAST GATE DRIVE, SUITE 200, MOUNT LAUREL, NJ 08054 FOR IMMEDIATE RELEASE InTest Reports Preliminary Second Quarter 2026 Results • Second Quarter Revenue Estimated to be Approximately $35 Million •

$SMCIHigh

Super Micro Already Told Us Its Revenue, Its Margins, and Its Orders. Tuesday's Report Has One Number Left.

Super Micro Computer (SMCI) preannounced fiscal Q4 results for the period ended June 30, saying revenue would be near the low end of $11.0B to $12.5B, gross margin 15% to 17%, and new orders over $60B, lifting backlog to record levels. The full results on Tuesday are expected to include a fiscal 2027 outlook. Shares trade in the low $30s, down about 45% from the 52-week high.

$PLBYMed

Honey Birdette’s comp sales jump 15%

Playboy Inc. said its Honey Birdette brand delivered 18.2% year-over-year sales growth in Q2 2026, with gross margin at 65.1%. Comparable store sales rose 15%. Playboy reported group sales up 11% to US$31.2m, DTC revenue at US$19.5m, and net income of US$0.2m versus a US$7.7m loss a year earlier.

$EVERMedAI 8/10

Why EverQuote (EVER) Stock Is Up Today

EverQuote (NASDAQ:EVER) shares rose about 9% after the insurance marketplace reported Q2 results and guidance. Revenue increased 25% to $195.1 million, adjusted EBITDA rose 37% to a record $30.1 million, and management projected Q3 revenue of $198–$208 million and adjusted EBITDA of $28–$31 million. The stock closed at $25.71, up 7.9%.

InTest (INTT) Q2 2026 Earnings Call Transcript — alphai